Imagen de Portada

Naloxone dosing: An evolving unregulated drug landscape, care setting considerations, and the need for research

Fuente: Wiley Open Access

Guardado en:

Detalles Bibliográficos
Autores principales:	James S. H. Wong, Anthony Lau, Pouya Azar
Formato:	Artículo Open Access
Publicado:	Wiley 2025
Materias:	Addiction
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Differences in heroin overdose risk associated with the unregulated drug market: Insights from a supervised injecting facility in Melbourne, Australia
por: Nathan C. Stam, et al.
Publicado: (2024)

Research is needed to guide contingency management implementation across populations and settings
por: Richard Rawson, et al.
Publicado: (2024)

Commentary on Nieto et al .: The heterogeneity of drug craving and considerations as a treatment endpoint
por: Justin C. Strickland, et al.
Publicado: (2026)

On the need and contents of a specific addiction recovery research agenda
por: William L. White, et al.
Publicado: (2026)

Do we need clinical trials of high dose stimulant agonist treatment for stimulant use disorders?
por: Wayne Hall, et al.
Publicado: (2024)

Recovery support services as part of the continuum of care for alcohol or drug use disorders
por: Ed Day, et al.
Publicado: (2025)

Working with, learning from and giving back: Principles for collaborative research with people who use drugs
por: Magdalena Harris
Publicado: (2026)

Commentary on D'Agata Mount et al.: Higher dose buprenorphine to improve retention in opioid use disorder treatment, prevent relapse, and optimize integrated care interventions
por: Paolo Mannelli
Publicado: (2024)

‘If you've ever experienced it, you'd feel differently’: Exploring willingness and skepticism toward using higher dose naloxone products among people who use drugs in Maryland, United States
por: Laura N. Sisson, et al.
Publicado: (2026)

The ReCoDe addiction research consortium: Losing and regaining control over drug intake—Findings and future perspectives
por: Rainer Spanagel, et al.
Publicado: (2024)

Target trial emulation for addiction research—A useful method but not a panacea
por: Philip James Clare, et al.
Publicado: (2026)

Treadmill Exercise Training Ameliorates Apoptotic Cells and DNA Oxidation in the Cerebral Cortex of Rats Exposed to Chronic Ketamine Abuse
por: Salar Sabziparvar, et al.
Publicado: (2025)

Commentary on ter Laak et al .: The importance of drug market information and differentiating drug use patterns
por: Rory Verhagen, et al.
Publicado: (2024)

‘Deaths of despair’: A term that needs to be retired
por: Shane Darke, et al.
Publicado: (2025)

The need for multi‐participant alcohol administration studies
por: Kasey G. Creswell, et al.
Publicado: (2024)

Alcohol and drug use and attainment of pregnancy preferences in the southwestern United States: A longitudinal cohort study
por: Sarah Raifman, et al.
Publicado: (2025)

Primary care's most pressing needs to address opioid use disorder: A qualitative study
por: Elise A. Robertson, et al.
Publicado: (2026)

Broad evidence of xylazine in the UK illicit drug market beyond heroin supplies: Triangulating from toxicology, drug‐testing and law enforcement
por: Caroline S. Copeland, et al.
Publicado: (2024)

Nitrous oxide addiction or not, action is needed. A response to commentaries
por: Sammie Back, et al.
Publicado: (2024)

Changing trends in drug overdose mortality in Spain, 2001–2022
por: Florencia Giné, et al.
Publicado: (2025)

Decentering alcohol: Non‐drug pleasure and reinforcement as an alternative target
por: Samuel F. Acuff, et al.
Publicado: (2025)

Navigating the digital age: The need for online‐specific gambling marketing regulations
por: Raffaello Rossi, et al.
Publicado: (2024)

A heroin overdose laboratory model: How do escalating doses of diamorphine alter respiratory function in a diamorphine‐treated population?
por: Basak Tas, et al.
Publicado: (2025)

Commentary on Pardo et al.: Whatever the past situation, drug precursor chemicals may in future represent an important source for synthetic drug production in Afghanistan and surrounding countries
por: Alexander Soderholm, et al.
Publicado: (2024)

Isaac Campos. Home grown: Marijuana and the origins of Mexico's war on drugs
por: Wayne Hall, et al.
Publicado: (2025)

We need better measures to understand the influence of social media on substance use
por: Benjamin Riordan, et al.
Publicado: (2025)

Questioning methadone split‐dosing for analgesia among hospitalized patients with opioid use disorder
por: Dale Terasaki, et al.
Publicado: (2024)

Health care service utilization and drug overdose death: A national nested case–control registry study
por: Linn Gjersing, et al.
Publicado: (2024)

You have to be alive to enjoy the porridge: The role of Goldilocks naloxone dosing in a world of hungry bears
por: Jake R. Morgan, et al.
Publicado: (2025)

Prescribing practices in opioid agonist treatment and changes in compliance to clinical dosing guidelines in British Columbia, Canada
por: Brenda Carolina Guerra‐Alejos, et al.
Publicado: (2024)

Fatal drug overdoses in healthcare workers: A thematic framework analysis of coroner reports
por: Thikra Algahtani, et al.
Publicado: (2025)

The association of methadone use with physical function and frailty among persons who inject drugs
por: Grace L. Kulik, et al.
Publicado: (2025)

Trends in fentanyl‐containing drug samples seized by law enforcement agencies across Canada
por: Shaleesa Ledlie, et al.
Publicado: (2026)

The International Scientific Forum on Alcohol Research (ISFAR) critiques of alcohol research: Promoting health benefits and downplaying harms
por: James M. Clay, et al.
Publicado: (2025)

Characteristics of drug‐related deaths among individuals identified as LGBTQ+ in the United Kingdom, 1997–2024
por: Emmert Roberts, et al.
Publicado: (2025)

Empirically contrasting urine drug screening‐based opioid use disorder treatment outcome definitions
por: Laura Brandt, et al.
Publicado: (2024)

Comparison of strength and adulteration between illicit drugs obtained from cryptomarkets versus off‐line
por: Leigh Coney, et al.
Publicado: (2024)

Temporal and geographical patterns of nitazene detections in drug samples and biospecimens in the United States, 2019–2024
por: David T. Zhu, et al.
Publicado: (2026)

High temporal resolution monitoring of illicit drug consumption across England via wastewater analysis
por: Helena Rapp‐Wright, et al.
Publicado: (2026)

A systematic review of reviews on comprehensive community initiatives to prevent or reduce alcohol and other drug harms
por: Peter John Gates, et al.
Publicado: (2025)